| [1] |
Martin PL, Oneda S, Treacy G.Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system[J]. Am J Reprod Immunol, 2007, 58(2):138-149.
|
| [2] |
Hazes JM, Coulie PG, Geenen V, et al. Rheumatoid arthritis and pregnancy: Evolution of disease activity and pathophysiological considerations for drug use[J]. Rheumatology (Oxford), 2011, 50(11):1955-1968.
|
| [3] |
Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: A causal relationship[J]. J Rheumatol, 2006, 33(5):1014-1017.
|
| [4] |
Crijns HJ, Jentink J, Garne E, et al. The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population[J]. J Rheumatol, 2011, 38(9):1871-1874.
|
| [5] |
Carter JD, Ladhani A, Ricca LR, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the Food and Drug Administration database[J]. J Rheumatol, 2009, 36(3):635-641.
|
| [6] |
Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations[J]. J Crohns Colitis, 2010, 4(1):63-101.
|
| [7] |
Vasiliauskas EA, Church JA, Silverman N, et al. Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn[J]. Clin Gastroenterol Hepatol, 2006, 4(10):1255-1258.
|
| [8] |
Ostensen M, Eigenmann GO. Etanercept in breast milk[J]. J Rheumatol, 2004, 31(5):1017-1018.
|
| [9] |
Mahmood I, Green MD. Drug interaction studies of therapeutic proteins or monoclonal antibodies[J]. J Clin Pharmacol, 2007, 47(12):1540-1554.
|
| [10] |
Ojeda-Uribe M, Afif N, Dahan E, et al. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases[J]. Clin Rheumatol, 2013, 1-6.
|
| [11] |
Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab[J]. Blood, 2011, 117(5):1499-1506.
|
| [12] |
Vinet E, Pineau C, Gordon C, et al. Biologic therapy and pregnancy outcomes in women with rheumatic diseases[J]. Arthritis Care Res, 2009, 61(5):87-92.
|
| [13] |
Pham T, Claudepierre P, Constantin A, et al. Abatacept therapy and safety management[J]. Joint Bone Spine, 2009, 76:S3-S55.
|
| [14] |
Rubbert-Roth A, Goupille PM, Moosavi S, et al. First experiences with pregnancies in RA patients receiving tocilizumab therapy[J]. Arthritis Rheum, 2010, 62(Suppl 10):384.
|
| [15] |
Berger CT, Recher M, Steiner U, et al. A patient's wish: Anakinra in pregnancy[J]. Annals Rheum Dis, 2009, 68(11):1794-1795.
|